GlassScriptPhysician profile
Joann Ramsey
NPI 1598792368
$4,513.41
in general payments reported to CMS, 2019-2025
49 companies · $1,054 in 2025
The $1,054 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $607 · 2022: $893 · 2023: $979 · 2024: $981 · 2025: $1,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,606 · Education: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,605.54 |
| Education | $407.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $468.78 | 2021-2025 | Erleada, Darzalex, Talvey |
| Novartis Pharmaceuticals Corporation | $450.10 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $420.13 | 2021-2025 | Imfinzi, Enhertu |
| Pfizer INC. | $411.15 | 2021-2025 | |
| Abbvie INC. | $255.48 | 2024-2025 | |
| Seagen INC. | $253.64 | 2021-2024 | Tukysa, Padcev |
| Merck Sharp & Dohme LLC | $213.44 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Genzyme Corporation | $194.33 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $188.95 | 2021-2023 | |
| Incyte Corporation | $161.61 | 2021-2025 | Monjuvi, Pemazyre, Jakafi |
| E.R. Squibb & Sons, L.L.C. | $130.88 | 2022-2025 | Opdivo |
| Celgene Corporation | $125.96 | 2021-2023 | Reblozyl |
| Daiichi Sankyo INC. | $114.91 | 2021-2025 | Enhertu, Injectafer |
| Sumitomo Pharma America, INC. | $110.77 | 2023-2025 | Orgovyx |
| Ipsen Biopharmaceuticals, INC | $74.49 | 2021-2025 | Onivyde |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joann Ramsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.